Etoposide
Records for this ingredient, by country (identity only).
ATC L01CB01 · 9 markets · 100 records
GB 26 records · 6 shown of 6
- 50 mgcapsuleVePesidManufacturer: Alliance Healthcare (Distri…、Manufacturer: Neon Healthcare Ltd
- 100 mg/5 mLinjectionEposin 500mg/25ml concentrate for solution for infusion vialsEtoposide 100mg/5ml concentrate for solution for infusion vials、Vepesid 100mg/5ml solution for infusion vials
- 100 mgcapsuleVePesidManufacturer: Alliance Healthcare (Distri…、Manufacturer: Neon Healthcare Ltd
- 100 mg per mL / per unit basis not statedinjectionEtopophos 100mg powder for solution for injection vialsManufacturer: Imported
- 500 mg/25 mLinjectionEposin 500mg/25ml concentrate for solution for infusion vialsEtoposide 100mg/5ml concentrate for solution for infusion vials
- 200 mg/10 mLinjectionEtoposide 100mg/5ml concentrate for solution for infusion vialsManufacturer: Hospira UK Ltd
US 19 records · 5 shown of 5
- 50 mgcapsuleVePesidManufacturer: Mylan Pharmaceuticals Inc.
- 100 mg/5 mLinjectionAvopef
- 100 mg per mL / per unit basis not statedinjectionETOPOPHOS
- 20 mg per mL / per unit basis not statedinjectionManufacturer: Accord Healthcare Inc.Manufacturer: BluePoint Laboratories、Manufacturer: Fresenius Kabi USA, LLC、Manufacturer: Hikma Pharmaceuticals USA I…、Manufacturer: Meitheal Pharmaceuticals In…
- 500 mg/25 mLinjectionAvopef
AU 17 records · 7 shown of 7
- 50 mgcapsuleVePesidVEPESID Etoposide 50mg capsule blister pack
- 100 mg/5 mLinjectionEtoposide Ebewe
- 100 mgcapsuleVePesidVEPESID Etoposide 50mg capsule blister pack
- 1,136 mg per mL / per unit basis not statedinjectionETOPOPHOSETOPOPHOS etoposide 500mg (as phosphate) powder for injection vial
- 113.6 mg per mL / per unit basis not statedinjectionETOPOPHOS Etoposide Phosphate 113.6mg (equivalent to 100mg etoposide) powder for injection vial
- 20 mg/mL per mL / per unit basis not statedinjectionETOPOSIDE EBEWE etoposide 50 mg/2.5 mL injection vial
- 567.8 mg per mL / per unit basis not statedinjectionETOPOPHOS etoposide 500mg (as phosphate) powder for injection vial
3 records · 0 manufacturers 3 registros · 0 fabricantes 3 个记录 · 0 个厂家 3 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名ETOPOPHOS ×2Etoposide Ebewe ×1VePesid ×5
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
JP 9 records · 3 shown of 3
- 50 mgcapsuleベプシドカプセル50mgラステットSカプセル50mg
- 100 mg/5 mLinjectionエトポシド点滴静注100mg「NIG」エトポシド点滴静注液100mg「SN」、エトポシド点滴静注液100mg「サンド」、ベプシド注100mg、ラステット注100mg/5mL
- 25 mgcapsuleベプシドカプセル50mgラステットSカプセル50mg
FR 8 records · 5 shown of 5
- 50 mgcapsuleCELLTOP 25 mg, capsule molle
- 100 mg/5 mLinjectionETOPOSIDE TEVA 100 mg/5 ml, solution injectable pour perfusion
- 20 mg/1 mLinjectionETOPOSIDE ACCORD 20 mg/mL, solution à diluer pour perfusionETOPOSIDE HIKMA 20 mg/mL, solution à diluer pour perfusion、ETOPOSIDE TEVA 20 mg/ml, solution à diluer pour perfusion、ETOPOSIDE VIATRIS 20 mg/ml, solution à diluer pour perfusion
- 200 mg/10 mLinjectionETOPOSIDE TEVA 100 mg/5 ml, solution injectable pour perfusion
- 113.6 mg per mL / per unit basis not statedinjectionETOPOPHOS 100 mg, lyophilisat pour usage parentéral
HK 4 records · 0 shown of 0
4 records · 0 manufacturers 4 registros · 0 fabricantes 4 个记录 · 0 个厂家 4 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名ETOPOSID EBEWE CONC FOR IV INF 20MG/ML ×1ETOPOSIDE INJ 20MG/ML (ABIC) ×1LASTET CAP 100MG ×4
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
CA 3 records · 2 shown of 2
TW 2 records · 2 shown of 2
- 50 mgcapsuleVePesid滅必治軟膠囊50毫克
- 100 mg per mL / per unit basis not statedinjectionFytosid for IV癌妥滅靜脈注射液 100毫克
SG 1 records · 1 shown of 1
- 20 mg/mL per mL / per unit basis not statedinjectionETOPOSIDE-TEVA INJECTION 20 mg/ml
Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.
| Strength / form / release | US | GB | CA | AU | SG | TW | HK | JP | FR |
|---|---|---|---|---|---|---|---|---|---|
| 50 mg capsule | Manufacturer: Mylan Pharmaceuticals Inc. VePesid | Manufacturer: Alliance Healthcare (Distri… ×2 Manufacturer: Neon Healthcare Ltd ×2 VePesid | VePesid | VePesid VEPESID Etoposide 50mg capsule blister pack | VePesid 滅必治軟膠囊50毫克 | ベプシドカプセル50mg ラステットSカプセル50mg | CELLTOP 25 mg, capsule molle | ||
| 100 mg/5 mL injection | Avopef | Eposin 500mg/25ml concentrate for solution for infusion vials Etoposide 100mg/5ml concentrate for solution for infusion vials Vepesid 100mg/5ml solution for infusion vials | Etoposide Ebewe | エトポシド点滴静注100mg「NIG」 エトポシド点滴静注液100mg「SN」 エトポシド点滴静注液100mg「サンド」+2ベプシド注100mg ラステット注100mg/5mL | ETOPOSIDE TEVA 100 mg/5 ml, solution injectable pour perfusion | ||||
| 100 mg capsule | Manufacturer: Alliance Healthcare (Distri… ×2 Manufacturer: Neon Healthcare Ltd ×2 VePesid | VePesid VEPESID Etoposide 50mg capsule blister pack | |||||||
| 100 mg per mL / per unit basis not stated cannot compare injection | ETOPOPHOS | Manufacturer: Imported Etopophos 100mg powder for solution for injection vials | Fytosid for IV 癌妥滅靜脈注射液 100毫克 | ||||||
| 20 mg per mL / per unit basis not stated cannot compare injection | Manufacturer: Accord Healthcare Inc. Manufacturer: BluePoint Laboratories ×4 Manufacturer: Fresenius Kabi USA, LLC+2Manufacturer: Hikma Pharmaceuticals USA I… ×4 Manufacturer: Meitheal Pharmaceuticals In… ×3 | ||||||||
| 20 mg/1 mL injection | ETOPOSIDE ACCORD 20 mg/mL, solution à diluer pour perfusion ETOPOSIDE HIKMA 20 mg/mL, solution à diluer pour perfusion ETOPOSIDE TEVA 20 mg/ml, solution à diluer pour perfusion+1ETOPOSIDE VIATRIS 20 mg/ml, solution à diluer pour perfusion | ||||||||
| 500 mg/25 mL injection | Avopef | Eposin 500mg/25ml concentrate for solution for infusion vials Etoposide 100mg/5ml concentrate for solution for infusion vials | |||||||
| 200 mg/10 mL injection | Manufacturer: Hospira UK Ltd Etoposide 100mg/5ml concentrate for solution for infusion vials | ETOPOSIDE TEVA 100 mg/5 ml, solution injectable pour perfusion | |||||||
| 25 mg capsule | ベプシドカプセル50mg ラステットSカプセル50mg | ||||||||
| 1,136 mgRecorded as: 1.136 g per mL / per unit basis not stated cannot compare injection | ETOPOPHOS ETOPOPHOS etoposide 500mg (as phosphate) powder for injection vial | ||||||||
| 113.6 mg per mL / per unit basis not stated cannot compare injection | ETOPOPHOS Etoposide Phosphate 113.6mg (equivalent to 100mg etoposide) powder for injection vial | ETOPOPHOS 100 mg, lyophilisat pour usage parentéral | |||||||
| 20 mg/mL per mL / per unit basis not stated cannot compare injection | ETOPOSIDE EBEWE etoposide 50 mg/2.5 mL injection vial | ETOPOSIDE-TEVA INJECTION 20 mg/ml | |||||||
| 20 mg per mL / per unit basis not stated cannot compare liquid | Etoposide | ||||||||
| 567.8 mg per mL / per unit basis not stated cannot compare injection | ETOPOPHOS etoposide 500mg (as phosphate) powder for injection vial | ||||||||
unknown | ETOPOPHOS Etoposide Ebewe VePesid | ETOPOSID EBEWE CONC FOR IV INF 20MG/ML ETOPOSIDE INJ 20MG/ML (ABIC) LASTET CAP 100MG |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
3 more strength/form rows are recorded only in CA · JP · FR and are not shown in this table. Hay 3 filas de concentración/forma registradas solo en CA · JP · FR que no se muestran en esta tabla. 另有 3 个规格/剂型仅在 CA · JP · FR 有记录（未在本表显示）。 另有 3 個規格/劑型僅在 CA · JP · FR 有記錄（未在本表顯示）。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
The same ingredient can carry completely different
brand names in different countries, and the same name can point to a different ingredient.
Listed by country — not interchangeable.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.